Detalles de la búsqueda
1.
Role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta-analysis.
J Gastroenterol Hepatol
; 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38686439
2.
Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients.
Cancer Immunol Immunother
; 72(7): 1957-1969, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36811662
3.
MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway.
Cancer Cell Int
; 23(1): 188, 2023 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37653482
4.
The Association of Glycemic Index, Glycemic Load, and Daily Carbohydrates Intake with the Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Nutr Cancer
; 75(2): 461-469, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36411493
5.
Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis.
Cancer Immunol Immunother
; 71(7): 1633-1644, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34750662
6.
Effects of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α overexpression on hepatocellular carcinoma survival: A systematic review with meta-analysis.
J Gastroenterol Hepatol
; 36(6): 1487-1496, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33393670
7.
Comprehensive molecular analysis identifies RET alterations association with response of ICIs in multi-immunotherapy cohorts.
Int Immunopharmacol
; 126: 111281, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38061115
8.
Neoadjuvant immunotherapy based on PD-1/L1 Inhibitors for gastrointestinal tumor: a review of rationale and clinical advances.
Int J Surg
; 2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38518083
9.
The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Expert Rev Anticancer Ther
; 24(5): 303-312, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38623811
10.
Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades.
J Cancer Res Clin Oncol
; 149(4): 1425-1441, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35482077
11.
Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis.
J Cancer Res Clin Oncol
; 149(5): 1993-2008, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35767193
12.
Evaluating liver function and the impact of immune checkpoint inhibitors in the prognosis of hepatocellular carcinoma patients: A systemic review and meta-analysis.
Int Immunopharmacol
; 114: 109519, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36459922
13.
Systemic therapy with or without locoregional therapy for advanced hepatocellular carcinoma: A systematic review and network meta-analysis.
Crit Rev Oncol Hematol
; 184: 103940, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36805079
14.
Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity.
Cell Death Dis
; 14(7): 404, 2023 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414748
15.
Regional and sex differences in the mortality risk associated with primary liver cancer in obesity: A systematic review and meta-analysis.
Nutrition
; 113: 112097, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37406391
16.
The association of fatty liver and risk of hepatocellular carcinoma in HBV or HCV infected individuals: a systematic review and meta-analysis.
Expert Rev Gastroenterol Hepatol
; 17(2): 189-198, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36625022
17.
Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis.
Expert Rev Gastroenterol Hepatol
; 17(1): 73-83, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36476076
18.
Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis.
Clin Exp Med
; 23(6): 2115-2129, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36385419
19.
Anthropometric indicators of adiposity and risk of primary liver cancer: A systematic review and dose-response meta-analysis.
Eur J Cancer
; 185: 150-163, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36996625
20.
Performance of GALAD score and serum biomarkers for detecting NAFLD-related HCC: a systematic review and network meta-analysis.
Expert Rev Gastroenterol Hepatol
; 17(11): 1159-1167, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37929312